Online Inquiry
  •  

Arginase-1 gRNA Lentiviral Particle for Macrophage Engineering (MTS-0124-LX22)

Overview

Description
The ready-to-use Arginase-1 gRNA Lentiviral Particle is packaged using 3rd generation of lentiviral packaging system, supporting macrophage cell engineering research.
Product Type
Virus Particles
Application Scenario
For in vivo and in vitro macrophage engineering

Target Specification

Engineering Approach
Target KO gRNA Contruction Lentivirus
Species
Human
Target
Arginase-1 gRNA
Alternative Names
Arginase 1
Full Name
Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exist (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type I isoform encoded by this gene, is a cytosolic enzyme and expressed predominantly in the liver as a component of the urea cycle. Inherited deficiency of this enzyme results in argininemia, an autosomal recessive disorder characterized by hyperammonemia. Two transcript variants encoding different isoforms have been found for this gene.
UniprotID
GeneID
Applications
Improve macrophages persist in solid tumors
Reference
DeNardo, David G, and Brian Ruffell. "Macrophages as regulators of tumour immunity and immunotherapy." Nature reviews. Immunology vol. 19,6 (2019): 369-382. doi:10.1038/s41577-019-0127-6

Product Specification

Packaging System
Lentivirus
Titer
>1E8 TU/mL
Size
200uL; 1mL
Mycoplasma Testing
Negative
Sterility Testing
Negative
Shipping
Dry ice
Storage
Stored at -80°C for long term.
Handling Notes
Avoid multiple freeze/thaw cycles.
Restriction
RUO

For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.

CONTACT US
(USA)
(UK)
(Germany)
ADDRESS

> Global

Copyright © 2024 Creative Biolabs. All Rights Reserved.